Command Palette

Search for a command to run...

Clinical Trials · NCT01761318

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Leiden University Medical Center
Enrollment
50
Start date
Nov 2013
Locations
1 site, Netherlands
Primary endpoint
Stroke volume
View Liraglutide compound reference